Various blood cancers, including acute lymphoblastic leukaemia and acute myeloid leukaemia (AML), also exhibit elevated MERTK expression [33, 34], with its expression crucial for tumour cells to evade innate immune surveillance. Here, MERTK is linked to acute myeloid leukemia.